These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 238717)

  • 1. Effects of thioproperazine and apomorphine on dopamine synthesis in the mesocortical dopaminergic systems.
    Scatton B; Thierry AM; Glowinski J; Julou L
    Brain Res; 1975 May; 88(2):389-93. PubMed ID: 238717
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery of the mesocortical dopaminergic system: some pharmacological and functional characteristics.
    Thierry AM; Tassin JP; Blanc G; Stinus L; Scatton B; Glowinski J
    Adv Biochem Psychopharmacol; 1977; 16():5-12. PubMed ID: 883554
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics.
    Scatton B; Glowinski J; Julou L
    Brain Res; 1976 Jun; 109(1):184-9. PubMed ID: 6117
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific distribution of metabolic alterations in cerebral cortex following apomorphine administration.
    McCulloch J; Savaki HE; McCulloch MC; Sokoloff L
    Nature; 1979 Nov; 282(5736):303-5. PubMed ID: 503202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of dopaminergic terminals and absence of dopaminergic cell bodies in the cerebral cortex of the cat.
    Thierry AM; Hirsch JC; Tassin JP; Blanc G; Glowinski J
    Brain Res; 1974 Oct; 79(1):77-88. PubMed ID: 4425954
    [No Abstract]   [Full Text] [Related]  

  • 6. Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation.
    Fuxe K; Corrodi H; Hökfelt T; Lidbrink P; Ungerstedt U
    Med Biol; 1974 Apr; 52(2):121-32. PubMed ID: 4837435
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine receptors and cholinergic neurons in the rat neostriatum.
    Guyenet PG; Javoy F; Agid Y; Beaujouan JC; Glowinski J
    Adv Neurol; 1975; 9():43-51. PubMed ID: 238376
    [No Abstract]   [Full Text] [Related]  

  • 8. hypobaric hypoxia: central catecholamine levels and cortical PO2 and avoidance response in rats treated with apomorphine.
    Saligaut C; Moore N; Boulu R; Plotkine M; Leclerc JL; Prioux-Guyonneau M; Boismare F
    Aviat Space Environ Med; 1981 Mar; 52(3):166-70. PubMed ID: 7225019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic drugs and dopamine uptake inhibition.
    Halaris AE; Freedman DX
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():247-58. PubMed ID: 3829
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of striatal dopamine synthesis in rats injected chronically with neuroleptics in their early life.
    Velley L; Blanc G; Tassin JP; Thierry AM; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(1):97-102. PubMed ID: 240129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
    Mantovani P; Bartolini A; Pepeu G
    Adv Biochem Psychopharmacol; 1977; 16():423-7. PubMed ID: 883550
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopaminergic terminals in the rat cortex.
    Thierry AM; Blanc G; Sobel A; Stinus L; Glowinski J
    Science; 1973 Nov; 182(4111):499-501. PubMed ID: 4744179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of apomorphine in quantified electroencephalography in the frontal cortex: changes with dose and time.
    Shvaloff A; Tesolin B; Sebban C
    Neuropharmacology; 1988 Dec; 27(12):1313-7. PubMed ID: 3244409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.
    Guyenet PG; Javory AF; Beaujouan JC; Rossier BJ; Glowinski J
    Brain Res; 1975 Feb; 84(2):227-44. PubMed ID: 234276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased release of dopane from striatal dopaminergic terminals in the rat after treatment with a neuroleptic: thioproperazine.
    Cheramy A; Besson MJ; Glowinski J
    Eur J Pharmacol; 1970 May; 10(2):206-14. PubMed ID: 4392817
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of thioproperazine on dopamine and noradrenaline metabolism in chronic schizophrenia].
    Panisset VC; Albert JM; Rocheleau LP; Dhaiti G; Tétreault L
    Laval Med; 1970 Sep; 41(7):917-22. PubMed ID: 4396422
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of levodopa and apomorphine on neuronal population oscillations in the cortico-basal ganglia loop circuit in vivo in experimental parkinsonism.
    Kühn J; Haumesser JK; Beck MH; Altschüler J; Kühn AA; Nikulin VV; van Riesen C
    Exp Neurol; 2017 Dec; 298(Pt A):122-133. PubMed ID: 28893517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of apomorphine-induced inhibition of vocalisation afterdischarge response by theophylline.
    Paalzow G; Paalzow L
    Life Sci; 1975 Oct; 17(7):1145-51. PubMed ID: 1196004
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ; Bunney EB; Roth RH
    Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some aspects of dopamine in the central nervous system.
    Carlsson A
    Adv Neurol; 1974; 5():59-68. PubMed ID: 4155236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.